Answers are grounded in this paper and cite their sources.
Histochemical staining patterns may vary with age because of changes in cell number, differentiation state, marker expression, tissue geometry, or pre-analytical conditions. Recent data indicate that epithelial tuft-cell abundance decreases and LGR5 immunoreactivity changes in the ageing human colon. We emphasize that marker-positive structures, cell number, and biological function are related but non-equivalent outcomes, particularly for rare epithelial populations and the cellularly complex enteric nervous system. To strengthen interpretation and international reproducibility, we propose a minimum framework combining orthogonal cell-identity markers, transcript-level confirmation in representative samples, donor-level statistical inference, transparent reporting of fixation, staining, imaging, and segmentation variables, and anatomically resolved denominators. A tiered validation pathway could enable laboratories with different technical capacities to generate comparable evidence through standardized bright-field histochemistry, regional multiplex-imaging hubs, and targeted analysis of discordant specimens. This approach could help define age-related staining differences as continuous spatial phenotypes for mechanistic investigation and clinical ageing research.
No takes yet. Share an insight, caveat, or question.
Vijayasimha et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: